Medicine & Health

Janet S. Lee, MD, a physician-scientist in the Division of Pulmonary & Critical Care at WashU Medicine, is internationally recognized for groundbreaking research in acute lung injury.

WashU biomedical engineers in Ismael Seáñez’s lab are evaluating which strategies and treatments are the most effective for spinal cord injuries.

A tool developed by WashU Medicine researchers can accurately distinguish among several major neurodegenerative diseases — including Alzheimer’s, Parkinson’s, frontotemporal dementia and dementia with Lewy bodies — as well as detect when these conditions overlap, potentially improving early diagnosis, monitoring and treatment.

Anne M. Drewry, MD, a nationally recognized leader in critical care medicine, has been installed as the inaugural Llorin-Roa Professor of Anesthesiology at WashU Medicine.

Biologists in WashU Arts & Sciences discovered that pH conditions can dramatically change how bacteria respond to antibiotics.

A cost-effective screening tool developed by WashU Medicine researchers allows for broader genomic testing for patients with peripheral neuropathy of unknown cause.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

WashU Medicine researchers at the Bright Center for Human Vision have developed gene therapies that help retinal cells clear toxic proteins in mouse and human models of retinitis pigmentosa, an inherited degenerative condition that causes blindness.